financetom
Business
financetom
/
Business
/
Flowserve's Core Market Weakness Seen Extending Into 2026, BofA Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Flowserve's Core Market Weakness Seen Extending Into 2026, BofA Says
Nov 14, 2025 8:22 AM

10:55 AM EST, 11/14/2025 (MT Newswires) -- Flowserve ( FLS ) faces continued weakness across its core oil and gas and chemicals end markets into 2026, BofA Securities said in a Friday note.

Leading indicators across those markets, which account for about 60% of Flowserve's ( FLS ) sales, continue to soften, suggesting organic growth will likely remain under pressure next year, analysts said. The firm expects Flowserve's ( FLS ) organic sales to lag expectations into 2026, consistent with its historical correlation to rig-count trends.

BofA said margins remain a relative strength, with the company positioned for about 120 basis points of year-over-year expansion next year. While margin performance has outpaced since 2022, it still lags peers over a longer horizon, the analysts said.

The firm added that near-term nuclear upside is already reflected in the stock. "While we think FLS is clearly a beneficiary longer-term and nuclear is accretive to overall margins, projects are long-cycle," it said.

BofA downgraded Flowserve ( FLS ) to neutral from buy and raised its price objective to $73 from $60.

Shares of Flowserve ( FLS ) were down 1% in recent trading.

Price: 67.29, Change: -0.71, Percent Change: -1.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Walt Disney Reportedly Lays Off Hundreds of Workers in Film, TV
--Walt Disney Reportedly Lays Off Hundreds of Workers in Film, TV
Jun 2, 2025
01:08 PM EDT, 06/02/2025 (MT Newswires) -- Price: 112.64, Change: -0.38, Percent Change: -0.34 ...
Jazz Pharmaceuticals Says Ziihera Achieves Over 3 Years Median Overall Survival in Gastroesophageal Cancer
Jazz Pharmaceuticals Says Ziihera Achieves Over 3 Years Median Overall Survival in Gastroesophageal Cancer
Jun 2, 2025
01:03 PM EDT, 06/02/2025 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) on Monday reported long-term survival results from a phase 2 trial evaluating its investigational HER2-targeted therapy Ziihera in combination with chemotherapy as a first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma. The company said median overall survival reached 36.5 months among the 46 enrolled patients, with...
Update: Alphabet Agrees to Settle Shareholder Lawsuit With $500 Million Compliance Overhaul Plan
Update: Alphabet Agrees to Settle Shareholder Lawsuit With $500 Million Compliance Overhaul Plan
Jun 2, 2025
01:08 PM EDT, 06/02/2025 (MT Newswires) -- (Updates with Google's ( GOOG ) response in the last paragraph.) Alphabet (GOOG, GOOGL) and Google ( GOOG ) have agreed to spend $500 million over the next 10 years to improve their compliance systems as part of a settlement with shareholders, according to court documents. The suit claimed that Alphabet engaged in...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved